BrightEdge Investments

BrightEdge has invested in 7 companies and its latest investment was Auron on Dec 17, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Auron is a Massachusetts-based biotechnology company that develops and commercializes therapies for the treatment of cancer.
$27M
Dec 17, 2024
-
TailorMed is a New York-based medical tech company that offers solutions including patient financial navigation and matching for healthcare providers and patients.
$40M
Nov 20, 2024
-
Vincere is a Massachusetts-based telehealth platform that provides solutions including personalized coaching and remote monitoring for smokers and vapers to quit smoking.
$1.8M
Oct 04, 2022
-
Auron is a Massachusetts-based biotechnology company that develops and commercializes therapies for the treatment of cancer.
$48M
Jul 19, 2022
-
CellCentric is an England-based biotechnology company that researches and develops small-molecule therapies for the treatment of patients with cancer.
-
Jan 25, 2022
-

Frequently Asked Questions about BrightEdge

  1. What is BrightEdge investing in?

    BrightEdge has invested in 7 companies including Auron, TailorMed and Vincere
  2. What company did BrightEdge invest in?

    BrightEdge invested in a total 7 companies including Auron, TailorMed and Vincere
  1. What are the top 5 investments by BrightEdge?

    The top companies in which BrightEdge invested are Auron, TailorMed, Vincere, Auron and CellCentric